Nicolas Javaud
@nicolasjavaud.bsky.social
Professeur de médecine d’urgence, chef de service
Reposted by Nicolas Javaud
In the API-CAT trial involving patients with active cancer and venous thromboembolism, extended anticoagulation with reduced-dose apixaban was noninferior to full-dose apixaban for preventing recurrent thromboembolic events. Full results: nej.md/41YkRZK
#ACC25 | @accintouch.bsky.social
#ACC25 | @accintouch.bsky.social
March 29, 2025 at 2:35 PM
In the API-CAT trial involving patients with active cancer and venous thromboembolism, extended anticoagulation with reduced-dose apixaban was noninferior to full-dose apixaban for preventing recurrent thromboembolic events. Full results: nej.md/41YkRZK
#ACC25 | @accintouch.bsky.social
#ACC25 | @accintouch.bsky.social
Reposted by Nicolas Javaud
L'épidémie de grippe commence juste à décliner mais elle reste encore très forte. Soyez prudent gardez les gestes barrières !
Source : Santé Publique France
Source : Santé Publique France
February 7, 2025 at 4:16 PM
L'épidémie de grippe commence juste à décliner mais elle reste encore très forte. Soyez prudent gardez les gestes barrières !
Source : Santé Publique France
Source : Santé Publique France
Reposted by Nicolas Javaud
